Amine Benmoussa
Angel Investor @ Karista
Toronto, Canada
Amine Benmoussa is a seed investor at Karista in Toronto focused on Medical and Hospital. Mr. Amine Benmoussa serves as an Associate Director at BDC Healthcare Venture. He joined BDC Venture Capital in 2011 and has over eight years of experience in banking and venture capital. Prior to joining the BDC Healthcare Fund team, Amine has held various roles in lending and investment at BMO Financial Group and was part of the New Economyinvestment team at the Solidarity Fund QFL, as a financial analyst-in-residence for the Life Sciences team and as a consultant for both the IT and Life Sciences investment teams. Amine is currently a board observer at Clementia Pharmaceuticals and Interface Biologics. He is also a selection committee member of the Philadelphia and Boston Canadian Technology Accelerators.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Amine Benmoussa invests in
Stages Amine Benmoussa invests in
Countries Amine Benmoussa invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Hospital 1 (50%)
- Health Care 1 (50%)
- Life Science 1 (50%)
- Neuroscience 1 (50%)
Stage
- Seed 1 (50%)
- Series B 1 (50%)
Country
- France 1 (50%)
- Switzerland 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SamanTree Medical is a swiss innovative medical device company providing a breakthrough imaging solution with the potential to improve patient care and cancer surgery outcome. Based on confocal microscopy, SamanTree Medical’s solution brings accurate and full margin control by the surgeon, in the operating room. | $6M / Series B / Apr 03, 2025 | ||
| RebrAIn makes it possible for individuals with severe Parkinson's or essential tremor disorder to get DBS treatment with precision targeting. Neurosurgeons can more accurately pinpoint the target location for electrode surgical insertion with the use of this SaaS service. Its innovative method predicts the treatment zone in each patient'sbrain using machine learning clinical patient data. | $4M / Seed / Mar 18, 2024 |
Co-Investors
About Karista
Karista is an early-stage venture capital firm created in 2001. We funded 90+ companies over the past two decades and support tomorrow’s game changers in the field of Health, Digital, Tech, and NewSpace. We have always worked to provide more than cash and partnered with entrepreneurs whom we share a common vision with.
Karista Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Agathe Testu
Secretary General - RCCI
|
|||
Baudouin Hue
Partner
|
|||
Benjamin Zerbib
Investment Director
|
|||
Catherine Boule
Managing Partner
|
|||
Elodie Feraille
Management Assistant
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Amine Benmoussa invest in?
Amine Benmoussa invests primarily in Medical, Hospital and Health Care startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Amine Benmoussa?
Public channels for Amine Benmoussa include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Amine Benmoussa last invest?
The most recent investment recorded for Amine Benmoussa closed in Apr 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
